Corrigendum to "Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data" Gynecol. Oncol. 154 (2019) 441-448

Cohen, Paul A.; Powell, Aime; Böhm, Steffen; Gilks, C. Blake; Stewart, Colin J. R.; Meniawy, Tarek M.; Bulsara, Max; Avril, Stefanie; Brockbank, Eleanor C.; Bosse, Tjalling; de Azevedo Focchi, Gustavo Rubino; Ganesan, Raji; Glasspool, Rosalind M.; Howitt, Brooke E.; Kim, Hyun-Soo; Lee, Jung-Yun; Le, Nhu D.; Lockley, Michelle; Manchanda, Ranjit; Mandalia, Trupti; McCluggage, W. Glenn; McNeish, Iain; Midha, Divya; Srinivasan, Radhika; Tan, Yun Yi; van der Griend, Rachael; Yunokawa, Mayu; Zannoni, Gian F.; Singh, Naveena

Corrigendum to "Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data" Gynecol. Oncol. 154 (2019) 441-448

Authors

Cohen, Paul A.

Powell, Aime

Böhm, Steffen

Gilks, C. Blake

Stewart, Colin J. R.

Meniawy, Tarek M.

Bulsara, Max

Avril, Stefanie

Brockbank, Eleanor C.

Bosse, Tjalling

Show 10 more

Issue Date

2021-04-01

Type

systematic review

Language

eng

Citation

Cohen, P. A. et al. (2021) ‘Corrigendum to “Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data” Gynecol. Oncol. 154 (2019) 441-448.’, Gynecologic oncology, 161(1), pp. 328–329. doi: 10.1016/j.ygyno.2021.01.032.

Publisher

Elsevier

License

Journal

Gynecologic oncology